Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

PMID: 36324795
Journal:
Year: 2022
Reference: medRxiv. 2022 Oct 25. doi: 10.1101/2022.10.22.22281221.
Impact factor:
Publication type: Letter or abstract
Authors: Abel, Laurent; Abolhassani, Hassan; Aiuti, Alessandro; Akcan, Ozge Metin; Al-Muhsen, Saleh Zaid; Allende, Luis M; Alonso-Arias, Rebeca; Arias, Andres Augusto; Asano, Takaki; Aytekin, Gokhan et al.
DOI: 10.1101/2022.10.22.22281221

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.

PMID: 35675076
Journal: JAMA Network Open
Year: 2022
Reference: JAMA Netw Open. 2022 Jun 1;5(6):e2215499. doi: 10.1001/jamanetworkopen.2022.15499.
Impact factor: 8.485
Publication type: Paper in international publication
Authors: Li, Ye, Lu, Kaifeng, Lipton, Richard B, Pozo-Rosich, Patricia, Blumenfeld, Andrew M, Dodick, David W, McAllister, Peter, Miceli, Rosa, Trugman, Joel M, Finnegan, Michelle et al.
DOI: 10.1001/jamanetworkopen.2022.15499

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.

PMID: 35675076
Journal: JAMA Network Open
Year: 2022
Reference: JAMA Netw Open. 2022 Jun 1;5(6):e2215499. doi: 10.1001/jamanetworkopen.2022.15499.
Impact factor:
Publication type: Paper in international publication
Authors: Blumenfeld, Andrew M; Dabruzzo, Brett; Dodick, David W; Finnegan, Michelle; Li, Ye; Lipton, Richard B; Lu, Kaifeng; McAllister, Peter; Miceli, Rosa; Pozo-Rosich, Patricia et al.
DOI: 10.1001/jamanetworkopen.2022.15499

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

PMID: 36037679
Journal: Journal of Stroke & Cerebrovascular Diseases
Year: 2022
Reference: J Stroke Cerebrovasc Dis. 2022 Oct;31(10):106742. doi: 10.1016/j.jstrokecerebrovasdis.2022.106742. Epub 2022 Aug 27.
Impact factor:
Publication type: Paper in international publication
Authors: Amarenco, Pierre; Bereczki, Daniel; Czlonkowska, Anna; Diener, Hans Christoph; Donovan, Mark; Endres, Matthias; Gailani, David; Hankey, Graeme J; Kahl, Anja; Kasner, Scott E et al.
DOI: 10.1016/j.jstrokecerebrovasdis.2022.106742

Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.

PMID: 35101083
Journal: Trials
Year: 2022
Reference: Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1.
Impact factor: 2.279
Publication type: Paper in international publication
Authors: Ofori, Sandra N, Marcucci, Maura, Painter, Thomas W, Conen, David, Leslie, Kate, Lomivorotov, Vladimir V, Sessler, Daniel, Chan, Matthew T V, Borges, Flavia K, Martinez Zapata, Maria J et al.
DOI: 10.1186/s13063-021-05992-1

Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.

PMID: 35101083
Journal: Trials
Year: 2022
Reference: Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1.
Impact factor:
Publication type: Paper in international publication
Authors: Abubakirov, Marat; Aguado, Hector J; Alfonsi, Pascal; Amir, Mohammed; Astrakov, Sergey V; Ayad, Sabry; Balasubramanian, Kumar; Bangdiwala, Shrikant I; Belley-Cote, Emily; Bhatt, Keyur et al.
DOI: 10.1186/s13063-021-05992-1

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

PMID: 34351426
Journal: European Heart Journal-Cardiovascular Pharmacotherapy
Year: 2022
Reference: Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
Impact factor: 6.617
Publication type: Letter or abstract
Authors: Rossello, Xavier, Dominguez-Rodriguez, Alberto, Barrabes, Jose A, Sanchez, Pedro L, Anguita, Manuel, Fernandez-Vazquez, Felipe, Pascual-Figal, Domingo, De la Torre Hernandez, Jose M, Ferraro, Stefano, Vetrano, Alfredo et al.
DOI: 10.1093/ehjcvp/pvab060

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

PMID: 34351426
Journal: European Heart Journal-Cardiovascular Pharmacotherapy
Year: 2022
Reference: Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
Impact factor:
Publication type: Letter or abstract
Authors: Aguero, Jaume; Anguita, Manuel; Barrabes, Jose A; De la Torre Hernandez, Jose M; Dominguez-Rodriguez, Alberto; Escalera, Noemi; Fernandez-Vazquez, Felipe; Ferraro, Stefano; Fuster, Valentin; Ibanez, Borja et al.
DOI: 10.1093/ehjcvp/pvab060

Re: Magdalena Gortz, Jan Philipp Radtke, Gencay Hatiboglu, et al. The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 2021;7:325-31.

PMID: 34992001
Journal: European Urology Focus
Year: 2022
Reference: Eur Urol Focus. 2022 Jan 3. pii: S2405-4569(21)00318-7. doi: 10.1016/j.euf.2021.12.007.
Impact factor: 5.996
Publication type: Letter or abstract
Authors: Morote, Juan, Planas, Jacques, Trilla, Enrique et al.
DOI: 10.1016/j.euf.2021.12.007

Re: Magdalena Gortz, Jan Philipp Radtke, Gencay Hatiboglu, et al. The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 2021;7:325-31.

PMID: 34992001
Journal: European Urology Focus
Year: 2022
Reference: Eur Urol Focus. 2022 Sep;8(5):1557-1558. doi: 10.1016/j.euf.2021.12.007. Epub 2022 Jan 3.
Impact factor:
Publication type: Letter or abstract
Authors: Morote, Juan; Planas, Jacques; Trilla, Enrique et al.
DOI: 10.1016/j.euf.2021.12.007

Reaching a consensus on the definition of "difficult" cholecystectomy among Spanish experts. A Delphi project. A qualitative study.

PMID: 35525412
Journal: International Journal of Surgery
Year: 2022
Reference: Int J Surg. 2022 Jun;102:106649. doi: 10.1016/j.ijsu.2022.106649. Epub 2022 May 4.
Impact factor: 6.071
Publication type: Paper in international publication
Authors: Latorre-Fragua, Raquel, Alcazar, Candido, Requena, Paola Melgar, de la Plaza, Roberto, Blanco Fernandez, Gerardo, Serradilla-Martin, Mario, Ramia, J M, Cudrado, Martin Bailon, Blas Laina, Juan Luis, Suescun, Federico Castillo et al.
DOI: 10.1016/j.ijsu.2022.106649

Reaching a consensus on the definition of "difficult" cholecystectomy among Spanish experts. A Delphi project. A qualitative study.

PMID: 35525412
Journal: International Journal of Surgery
Year: 2022
Reference: Int J Surg. 2022 Jun;102:106649. doi: 10.1016/j.ijsu.2022.106649. Epub 2022 May 4.
Impact factor:
Publication type: Paper in international publication
Authors: Alcazar, Candido; Andorra, Estaban Cugat; Azagra, Santiago; Ben, Santiago Lopez; Blanco Fernandez, Gerardo; Blas Laina, Juan Luis; Cecilia, David Martinez; Conde, Salvador Morales; Cruchaga, Pablo Marti; Cudrado, Martin Bailon et al.
DOI: 10.1016/j.ijsu.2022.106649

REACT Aspiration Catheters: Clinical Experience and Technical Considerations.

PMID: 35718472
Journal: Neurointervention
Year: 2022
Reference: Neurointervention. 2022 Jul;17(2):70-77. doi: 10.5469/neuroint.2022.00255. Epub 2022 Jun 20.
Impact factor: 0
Publication type: Review in international publication
Authors: Li, Jiahui; Ribo, Marc et al.
DOI: 10.5469/neuroint.2022.00255

REACT Aspiration Catheters: Clinical Experience and Technical Considerations.

PMID: 35718472
Journal: Neurointervention
Year: 2022
Reference: Neurointervention. 2022 Jul;17(2):70-77. doi: 10.5469/neuroint.2022.00255. Epub 2022 Jun 20.
Impact factor:
Publication type: Review in international publication
Authors: Li, Jiahui; Li, Jiahui; Ribo, Marc et al.
DOI: 10.5469/neuroint.2022.00255

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination.

PMID: 36016105
Journal: Vaccines
Year: 2022
Reference: Vaccines (Basel). 2022 Jul 29;10(8). pii: vaccines10081217. doi: 10.3390/vaccines10081217.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Cristina; Agusti, Antonia; Armadans, Lluis; Borras-Bermejo, Blanca; Campins, Magda; Cossio-Gil, Yolima; Martinez-Gomez, Xavier; Otero, Susana; Pares-Badell, Oleguer; Pinos, Laia et al.
DOI: 10.3390/vaccines10081217

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

PMID: 35475683
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.
Impact factor: 7.171
Publication type: Paper in international publication
Authors: Ruiz-Camps, Isabel, Bergas, Alba, Albasanz-Puig, Adaia, Fernandez-Cruz, Ana, Machado, Marina, Novo, Andres, van Duin, David, Garcia-Vidal, Carolina, Hakki, Morgan, Gudiol, Carlota et al.
DOI: 10.1128/spectrum.02292-21

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

PMID: 35475683
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar-Company, Juan; Albasanz-Puig, Adaia; Alvarez-Uria, Ana; Bergas, Alba; Capilla, Silvia; Carmona-Torre, Francisco; Carratala, Jordi; Castaldo, Nadia; Clerici, Teresa Daniela; Del Pozo, Jose Luis et al.
DOI: 10.1128/spectrum.02292-21

[Real-life WAKE study in narcolepsy patients with cataplexy treated with pitolisant and unresponsive to previous treatments].

PMID: 36169322
Journal: REVISTA DE NEUROLOGIA
Year: 2022
Reference: Rev Neurol. 2022 Oct 1;75(7):165-171. doi: 10.33588/rn.7507.2022090.
Impact factor:
Publication type: Paper in national publication
Authors: Del Rio-Villegas, R; Gaig-Ventura, C; Gomez-Barrera, M; Martinez-Orozco, F J; Romero-Santo Tomas, O; Yebenes-Cortes, M et al.
DOI: 10.33588/rn.7507.2022090

Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.

PMID: 35417564
Journal: CANCER
Year: 2022
Reference: Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13.
Impact factor: 6.86
Publication type: Paper in international publication
Authors: Gasior, Mercedes, Alvarez-Larran, Alberto, Garrote, Marta, Ferrer-Marin, Francisca, Perez-Encinas, Manuel, Mata-Vazquez, M Isabel, Bellosillo, Beatriz, Arellano-Rodrigo, Eduardo, Gomez, Montse, Garcia, Regina et al.
DOI: 10.1002/cncr.34195

Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.

PMID: 35417564
Journal: CANCER
Year: 2022
Reference: Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Larran, Alberto; Angona, Anna; Arellano-Rodrigo, Eduardo; Ayala, Rosa; Bellosillo, Beatriz; Caballero, Gonzalo; Carreno-Tarragona, Gonzalo; Cuevas, Beatriz; Del Orbe-Barreto, Rafael; Ferrer-Marin, Francisca et al.
DOI: 10.1002/cncr.34195

Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.

PMID: 36434742
Journal: Clinical and Translational Allergy
Year: 2022
Reference: Clin Transl Allergy. 2022 Nov;12(11):e12208. doi: 10.1002/clt2.12208.
Impact factor:
Publication type: Paper in international publication
Authors: Agache, Ioana; Amaral, Rita; Ansotegui, Ignacio J; Anto, Aram; Anto, Josep M; Bastl, Katharina; Bedbrook, Anna; Berger, Markus; Berger, Uwe; Bergmann, Karl C et al.
DOI: 10.1002/clt2.12208

Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience.

PMID: 36151933
Journal: TRANSFUSION
Year: 2022
Reference: Transfusion. 2022 Nov;62(11):2363-2369. doi: 10.1111/trf.17111. Epub 2022 Sep 24.
Impact factor:
Publication type: Paper in international publication
Authors: Bobillo, Sabela; Bosch, Francesc; Jimenez, Moraima; Miranda, Nayibe; Molero, Antonieta; Perez, Ana; Pons, Veronica; Sanchez, Angela; Sanchez, Carla; Tabares, Elizabeth et al.
DOI: 10.1111/trf.17111

Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura.

PMID: 35930694
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Dec 27;6(24):6219-6227. doi: 10.1182/bloodadvances.2022008028.
Impact factor:
Publication type: Paper in international publication
Authors: Atucha, Jon Ander; Avila Idrovo, Laura Francisca; Campuzano Saavedra, Veronica; Cid, Joan; Cruz, Naylen; de la Rubia, Javier; Del Rio-Garma, Julio; Fernandez Zarzoso, Miguel; Fernandez-Docampp, Marta; Freiria, Carmen et al.
DOI: 10.1182/bloodadvances.2022008028

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.

PMID: 35271707
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Jun 28;6(12):3606-3610. doi: 10.1182/bloodadvances.2021006922.
Impact factor: 6.799
Publication type: Letter whit IF
Authors: Reguera-Ortega, Juan Luis, Camacho-Arteaga, Lina, Schmidt, Christian, Marin-Niebla, Ana, Kersten, Marie Jose, Martin Garcia-Sancho, Alejandro, Zinzani, Pier Luigi, Corradini, Paolo, van Meerten, Tom, Subklewe, Marion et al.
DOI: 10.1182/bloodadvances.2021006922